Chris Markoch

Chris Markoch

InvestorPlace Contributor

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

Ocugen Looks Less Interesting With Each Passing Shot

By Chris Markoch, InvestorPlace Contributor

OCGN stock popped in February as investors anticipated revenue from a Covid-19 vaccine partnership. But with the U.S. looking to be well supplied, it's hard to see the opportunity.

8 Dividend Stocks Increasing Payouts in 2021

By Chris Markoch, InvestorPlace Contributor

A great way to select dividend stocks is to find companies that are increasing the amount of their dividend payout. Here are eight stocks that have recently issued sizable dividend increases.

Top Stocks 2021: If You Only Buy One Solar Stock, It Better Be Enphase Energy

By Chris Markoch, InvestorPlace Contributor

Some analysts say the time is right to buy the dip insolar stocks. Whenever you decide to jump in, there are several attractive candidates.  

Don’t Overlook Undervalued Paysafe Stock Now That Its Merger Is Complete

By Chris Markoch, InvestorPlace Contributor

PSFE stock is trending lower after going public. However, with no real bad news looming, the stock looks like an undervalued opportunity.

Both the Risk and Reward of Buying Fisker Stock Are Hiding in Plain Sight

By Chris Markoch, InvestorPlace Contributor

FSR stock may richly reward speculative investors in the EV sector. However the risks will also e obvious for investors to see as the company nears production.

Keep Your Eyes on Coupang, But Wait For a Better Price to Buy

By Chris Markoch, InvestorPlace Contributor

Coupang stock continues to trade at a premium after its IPO in March. If you don't yet hold a position, CPNG stock may look better on your watch list.

Buy Ethereum While Retail Investors Are Still in Charge

By Chris Markoch, InvestorPlace Contributor

Buying Ethereum makes sense because retail investors remain in charge of the crypto market and the blockchain is becoming more widely accepted.

7 Medical Marijuana Stocks For Your Waiting Room

By Chris Markoch, InvestorPlace Contributor

Marijuana stocks may still have some roadblocks until the U.S. market opens, but change is coming, and medical marijuana is leading the way.

Things Have Gotten Really Noisy With QuantumScape

By Chris Markoch, InvestorPlace Contributor

There's a lot of news around QuantumScape; but most of it is not good for QS stock. Until things quiet down the stock's recent floor may become its ceiling.

Can Nano Dimension Learn How to Print Money?

By Chris Markoch, InvestorPlace Contributor

NNDM stock got a major boost when Cathie Wood announced she was backing NNDM stock. But the company needs to show that its business can deliver much more revenue.

Load More